BIO News Alert Bio-Rad Laboratories (BIO) 120.32 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Rad Laboratories (BIO) 120.32 $BIO

Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
BPY: 23.40 (-0.01), BIO: 120.32 (-0.04), BALT: 2.47 (-0.11), CVE: 20.70 (-0.25), APC: 83.08 (-1.16)

Affymetrix, Binding Site Group Ink Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 4:25PM CST
Provider of life science tools and molecular diagnostic products, Affymetrix Inc. (AFFX), recently announced that its eBioscience business has entered into a multi-year distribution agreement with The Binding Site Group Ltd.
HBIO: 5.15 (-0.09), BIO: 120.32 (-0.04), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05)

Affymetrix Axiom Genotyping Platform Selected by Toshiba - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 5:10PM CST
The Axiom Genotyping Solution platform of Affymetrix (AFFX) has been selected by Toshiba's Healthcare Company as the platform for its newly launched genotyping service.
HBIO: 5.15 (-0.09), BIO: 120.32 (-0.04), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05)

Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
BUD: 115.51 (+0.09), BIO: 120.32 (-0.04), AVHI: 13.84 (+0.19), BBL: 42.86 (-0.19), WBAI: 19.70 (+0.19)

Bio-Rad Receives Premarket Application Approval for Its Geenius HIV 1/2 Supplemental Assay
Marketwired - Wed Nov 19, 3:45PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) , a global provider of life science research and clinical diagnostic products life science research and clinical diagnostic products, today announced that it has received Premarket Application approval from the U.S. Food and Drug Administration for Bio-Rad's Geenius(TM) HIV 1/2 Supplemental Assay (test).
BIO: 120.32 (-0.04), BIO.B: 120.51 (unch)

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Bio-Rad Laboratories, Inc.
PR Newswire - Wed Nov 12, 12:44PM CST
Levi & Korsinsky, LLP is investigating Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company" (NYSE: BIO) in connection with possible breaches of fiduciary duty by the Board of Directors of the Company.
BIO: 120.32 (-0.04)

Lifshitz & Miller Law Firm Announces Investigation of Barrett Business Services, Inc., Bio-Rad Laboratories, Inc., Pingtan Marine Enterprise Ltd., Rayonier Inc. and Salix Pharmaceuticals, Ltd.
PR Newswire - Tue Nov 11, 11:10AM CST
Barrett Business Services, Inc.
RYN: 28.31 (unch), BIO: 120.32 (-0.04), BBSI: 28.34 (+0.38), SLXP: 114.92 (-1.18), PME: 2.00 (+0.10)

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces an Investigation into Possible Breaches of Fiduciary Duties by the Board of Directors of Bio-Rad Laboratories, Inc.
Business Wire - Fri Nov 07, 3:39PM CST
Rigrodsky & Long, P.A. announces that it is investigating whether certain officers and directors of Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company" (NYSE: BIO) breached their fiduciary duties to shareholders.
BIO: 120.32 (-0.04)

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
BWEN: 5.67 (+0.11), AIRM: 43.03 (-0.10), CPF: 21.00 (+0.95), BIO: 120.32 (-0.04), BALT: 2.47 (-0.11)

Ryan & Maniskas, LLP Announces Investigation of Bio-Rad Laboratories, Inc.
PR Newswire - Wed Nov 05, 6:30PM CST
Ryan & Maniskas, LLP has commenced an investigation into potential securities law violations by certain officers of Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company" (NYSE: BIO).
BIO: 120.32 (-0.04)

BIO-RAD INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Bio-Rad Laboratories, Inc. Following Bribery Settlement with Securities and Exchange Commission and the U.S. Department of Justice
Business Wire - Wed Nov 05, 3:58PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. a partner at the law firm of Kahn Swick & Foti, LLC ("KSF" announces that KSF has commenced an investigation into Bio-Rad Laboratories, Inc. (NYSE: BIO).
BIO: 120.32 (-0.04)

Bio-Red Laboratories' (BIO) CEO Norman Schwartz on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 8:33PM CST

BIO: 120.32 (-0.04)

Bio-Rad posts 3Q profit
Automated Insights - Tue Nov 04, 5:36PM CST
HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO) on Tuesday reported net income of $11.5 million, or 39 cents per share, in its third quarter.
BIO: 120.32 (-0.04), BIO.B: 120.51 (unch)

Bio-Rad Laboratories (BIO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 3:55PM CST

BIO: 120.32 (-0.04)

Faruqi & Faruqi, LLP is Investigating Bio-Rad Laboratories, Inc. (BIO) on Behalf of its Shareholders
PR Newswire - Tue Nov 04, 3:48PM CST
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Bio-Rad Laboratories, Inc. ("Bio-Rad" or the "Company" (NYSE: BIO).
BIO: 120.32 (-0.04)

Robbins Arroyo LLP Is Investigating the Officers and Directors of Bio-Rad Laboratories, Inc. (BIO) on Behalf of Shareholders
PR Newswire - Tue Nov 04, 3:47PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Bio-Rad Laboratories, Inc. (NYSE: BIO) breached their fiduciary duties to shareholders. Bio-Rad manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets.
BIO: 120.32 (-0.04)

Bio-Rad Labs misses by $0.47, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:43PM CST

BIO: 120.32 (-0.04)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Fire-Resistant Lubricants Offer a Quiet Value Shift

Updated Category News Views 67

Hydraulic fluid is not the sort of product that gets anyone pounding the table, and that is precisely why this little industrial pocket deserves a hard look. The fire-resistant lubricants market is estimated at $2.35 billion in 2026 and projected to reach $2.83 billion by 2031, implying a 3.74% compound annual growth rate. That is not a rocket ship. It is a slow-moving,...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 53

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 107

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 35

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading

Top 5 Most Recently Viewed Articles

Synetos Aerospace Partners with AFWERX for AI Flight System

Updated Category News Views 202

Synetos Aerospace made waves back when it teamed up with AFWERX to develop an AI-enabled flight augmentation system aimed at improving the safety and efficiency of uncrewed aircraft. This partnership was not just about spiffing up tech; it showcased a commitment to enhancing operational productivity while lightening the load for operators in the increasingly fast-paced...

Continue Reading
Haruhiko Kuroda Takes on New Role at Economic Research Center

Updated Category News Views 256

Haruhiko Kuroda's New Chapter in Economic Research Former Bank of Japan Governor Haruhiko Kuroda is set to begin an exciting new role as an adviser at the Japan Center for Economic Research starting in January. This significant change comes on the heels of his long and impactful tenure at the Bank of Japan, where he served for a decade, shaping the nation's monetary...

Continue Reading
APA Corporation Discusses Key Insights for Q3 2025 Results

Updated Category News Views 269

Insights into APA Corporation's Third-Quarter 2025 APA Corporation (NASDAQ: APA) has shared important details about its projected financial and operational outcomes for the third quarter of 2025. This information aims to guide investors and analysts in their own assessments, focusing on factors expected to influence the company's performance. Estimated Average Realized...

Continue Reading
FibroGen's Strategic Move with AstraZeneca Approved Sale

Updated Category News Views 145

FibroGen Secures Approval for Strategic Sale FibroGen, Inc. (NASDAQ: FGEN), based in San Francisco, has officially received approval from the China State Administration for Market Regulation for the sale of FibroGen International (Hong Kong) Ltd. to AstraZeneca Treasury Limited. This key decision marks a significant milestone as the company moves forward with its plans...

Continue Reading
Curaleaf Secures $100 Million Credit Deal to Boost Growth

Updated Category News Views 146

Curaleaf Expands Credit Facilities to Fuel Business Growth Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a prominent player in the cannabis sector, has made headlines by upscaling its revolving credit facility to a whopping $100 million with Needham Bank. This move marks a pivotal moment in the cannabis financing landscape. A Landmark Financing Achievement Boris...

Continue Reading